Vaccines Europe reflection paper on DG Research proposal to create a European Clinical Trials capacity/platform on infectious diseases

While Vaccines Europe supports the concept of creating a European Clinical Trials capacity/platform on infectious diseases we believe that pharmaceutical companies should be involved in defining the format and remit of the future platform to ensure that it responds to the needs of the industry.

Such a platform should have up to date information on clinical trial sites in the EU providing information on both enrolment capacity together with technical information. This paper outlines our position on both the requirements and recommendations for the project: